These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

726 related items for PubMed ID: 21460309

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Is there a clinical association of vancomycin MIC creep, agr group II locus, and treatment failure in MRSA bacteremia?
    de Sanctis JT, Swami A, Sawarynski K, Gerasymchuk L, Powell K, Robinson-Dunn B, Carpenter CF, Sims MD.
    Diagn Mol Pathol; 2011 Sep; 20(3):184-8. PubMed ID: 21817905
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Evaluation of vancomycin population susceptibility analysis profile as a predictor of outcomes for patients with infective endocarditis due to methicillin-resistant Staphylococcus aureus.
    Casapao AM, Davis SL, McRoberts JP, Lagnf AM, Patel S, Kullar R, Levine DP, Rybak MJ.
    Antimicrob Agents Chemother; 2014 Aug; 58(8):4636-41. PubMed ID: 24890596
    [Abstract] [Full Text] [Related]

  • 28. High-dose vancomycin therapy for methicillin-resistant Staphylococcus aureus infections: efficacy and toxicity.
    Hidayat LK, Hsu DI, Quist R, Shriner KA, Wong-Beringer A.
    Arch Intern Med; 2006 Oct 23; 166(19):2138-44. PubMed ID: 17060545
    [Abstract] [Full Text] [Related]

  • 29. Implementation of an antimicrobial stewardship pathway with daptomycin for optimal treatment of methicillin-resistant Staphylococcus aureus bacteremia.
    Kullar R, Davis SL, Kaye KS, Levine DP, Pogue JM, Rybak MJ.
    Pharmacotherapy; 2013 Jan 23; 33(1):3-10. PubMed ID: 23307539
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. More accurate measurement of vancomycin minimum inhibitory concentration indicates poor outcomes in meticillin-resistant Staphylococcus aureus bacteraemia.
    Shoji H, Maeda M, Shirakura T, Takuma T, Ugajin K, Fukuchi K, Ishino K, Niki Y.
    Int J Antimicrob Agents; 2015 Nov 23; 46(5):532-7. PubMed ID: 26364848
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Antibiotic choice may not explain poorer outcomes in patients with Staphylococcus aureus bacteremia and high vancomycin minimum inhibitory concentrations.
    Holmes NE, Turnidge JD, Munckhof WJ, Robinson JO, Korman TM, O'Sullivan MV, Anderson TL, Roberts SA, Gao W, Christiansen KJ, Coombs GW, Johnson PD, Howden BP.
    J Infect Dis; 2011 Aug 01; 204(3):340-7. PubMed ID: 21742831
    [Abstract] [Full Text] [Related]

  • 35. Quantifying the matrix of relationships between reduced vancomycin susceptibility phenotypes and outcomes among patients with MRSA bloodstream infections treated with vancomycin .
    Lodise TP, Drusano GL, Lazariu V, El-Fawal N, Evans A, Graffunder E, Stellrecht K, Mendes RE, Jones RN, Cosler L, McNutt LA.
    J Antimicrob Chemother; 2014 Sep 01; 69(9):2547-55. PubMed ID: 24840624
    [Abstract] [Full Text] [Related]

  • 36. Method-specific performance of vancomycin MIC susceptibility tests in predicting mortality of patients with methicillin-resistant Staphylococcus aureus bacteraemia.
    Chen SY, Liao CH, Wang JL, Chiang WC, Lai MS, Chie WC, Chang SC, Hsueh PR.
    J Antimicrob Chemother; 2014 Jan 01; 69(1):211-8. PubMed ID: 23997017
    [Abstract] [Full Text] [Related]

  • 37. Management of serious meticillin-resistant Staphylococcus aureus infections: what are the limits?
    Gould IM, Cauda R, Esposito S, Gudiol F, Mazzei T, Garau J.
    Int J Antimicrob Agents; 2011 Mar 01; 37(3):202-9. PubMed ID: 21300528
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Impact of initial vancomycin pharmacokinetic/pharmacodynamic parameters on the clinical and microbiological outcomes of methicillin-resistant Staphylococcus aureus bacteremia in children.
    Yoo R, So H, Seo E, Kim M, Lee J.
    PLoS One; 2021 Mar 01; 16(4):e0247714. PubMed ID: 33793589
    [Abstract] [Full Text] [Related]

  • 40. Risk factors for mortality in patients with persistent methicillin-resistant Staphylococcus aureus bacteraemia in a tertiary care hospital in Taiwan.
    Lin SH, Liao WH, Lai CC, Liao CH, Tan CK, Wang CY, Huang YT, Hsueh PR.
    J Antimicrob Chemother; 2010 Aug 01; 65(8):1792-8. PubMed ID: 20511366
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 37.